Colorectal, Gastroesophageal and Pancreatic Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Colorectal, Gastroesophageal and Pancreatic Cancer
Proceedings from a CME symposium held at the 2020
Gastrointestinal Cancers Symposium. Featuring perspectives from Drs
Crystal Denlinger, Howard S Hochster, John L Marshall, Michael J
Overman, Philip A Philip and Prof Eric Van Cutsem.
Introduction — Dr Neil Love (00:00)
The Emergence of Targeted Therapy for Patients with Metastatic
Colorectal Cancer (mCRC) and BRAF V600E Tumor Mutations; HER2 and
Other Potential Biomarkers — Dr Hochster (16:20)
Lingering Questions in the Selection and Sequence of Therapy
for Patients with mCRC — Dr Marshall (44:23)
Current and Emerging Role of Immune Checkpoint Inhibitors in
the Management of mCRC — Dr Overman (1:05:39)
Optimal Management of Metastatic Gastric/Gastroesophageal
Cancer — Dr Denlinger (1:33:29)
Contemporary Treatment Approaches for Patients with Pancreatic
Cancer — Dr Philip (1:53:28)
PARP Inhibition in Pancreatic Cancer; Promising Investigational
Strategies — Prof Van Cutsem (2:15:15)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.